Prasco Dapagliflozin Tablets

Dapagliflozin is a prescription medication used primarily to manage blood sugar levels in adults with type 2 diabetes. This specific bottle is an authorized generic manufactured and distributed by Prasco Laboratories. The original drug, Farxiga, was developed through a partnership between Bristol-Myers Squibb and AstraZeneca, though AstraZeneca eventually took full control of the diabetes alliance.

Prasco specializes in authorized generics, which are pharmaceutical products made by the original brand-name manufacturer but sold under a generic label. Because these are often manufactured on the same production lines as the brand-name drug, manufacturing may occur in various international facilities belonging to the technical owner, including locations in the United States, Puerto Rico, or Europe. Prasco acts as the primary US distribution partner for many of these specialized pharmaceutical launches.